PSA, Total ELISA Kit

Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.

Prostate-specific antigen assay for screening and monitoring of prostate cancer. Quantitative measurement of PSA in serum samples.

Chemiluminescence immunoassay for total prostate-specific antigen measurement with analytical sensitivity of 0.005 ng/ml and linearity up to 100 ng/ml.

Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.

Immunofluorescence test kit for simultaneous detection of AFP, CEA, and total PSA biomarkers. Used for cancer screening and monitoring in clinical laboratories and point-of-care settings. Provides rapid quantitative results for liver, colorectal, and prostate cancer assessment.

FIA-based quantitative test kit for PSA measurement in prostate health screening. Designed for point-of-care testing applications.

A lateral flow immunoassay test kit for detection of prostate-specific antigen levels. This test aids in prostate health screening and early detection of abnormalities.

A non-invasive, urine-sample-based diagnostic kit for prostate cancer detection and risk assessment. The kit utilizes PSA N-glycosylation analysis to detect asparagine-linked carbohydrates of PSA, providing comprehensive clinical insights into prostate cancer-related alterations. It employs recombinant antibody technology to ensure selectivity and cost-effectiveness, and is designed for simplicity, requiring no specialized or highly skilled operator personnel. The diagnostic method significantly reduces false-positive rates compared to conventional serum PSA tests.

An assay kit for the determination of Total Estrogens in human serum. This diagnostic test is designed for quantitative measurement of estrogen levels in clinical and research applications.

Non-invasive urine-based diagnostic test that analyzes asparagine-linked carbohydrates of PSA to detect prostate cancer and assess disease aggressiveness. The assay provides comprehensive N-glycomic profiling in a single test, reducing false positives and unnecessary clinical interventions.

Enzyme immunoassay for procalcitonin measurement. Aids in bacterial infection diagnosis and sepsis assessment.

A diagnostic test kit for measuring total prostate-specific antigen using immunofluorescence method. This reagent is designed for clinical laboratory use to detect t-PSA levels in patient samples.